ARCHIVES

Mace Rothenberg Leaves Vanderbilt For Pfizer Oncology.

This article is from The Cancer Letter archive.

Vol. 34 No. 42 | November 14, 2008

Download PDF Visit The Full Archive

Related Articles

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

DCT Board Approves Management Support, Drug Storage Concepts

March 3, 1989

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13

April 1, 1994

Unorthodox Panel Considers NIH Mandated Role In Study of Unconventional Medical Practices

June 26, 1992

House Preserves Funds For Space Station; Cancer Societies Reiterate Support For $170 Million Increase For NCI

August 7, 1992